Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Advancing the development of TRIP13 inhibitors: A high-throughput screening approach

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100233Source: DataRank Database

Advancing the development of TRIP13 inhibitors: A high-throughput screening approach is a research paper published in SLAS DISCOVERY (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Soma Ghosh ORCID,Laçin Yapindi ORCID,Eun Jeong Cho ORCID,Faye M. Johnson ORCID,Kevin N. Dalby ORCID

Live enrichment

PubMed:40228580 PMC:PMC12224672 OpenAlex:https://openalex.org/W4409382725

National Institutes of Health

Grant: R01CA248205

Cancer Prevention and Research Institute of Texas

Grant: RP210088

The University of Texas at Austin

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://www.slas-discovery.org/article/S2472-5552(25)00026-7/pdf

GOLDhttps://www.slas-discovery.org/article/S2472-5552(25)00026-7/pdf

publisherhttps://www.slas-discovery.org/article/S2472-5552(25)00026-7/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555225000267?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555225000267?httpAccept=text/plain

Fields of Study

Peptidase Inhibition and AnalysisCalcium signaling and nucleotide metabolismSignaling Pathways in DiseaseMedicineChemistryHigh-Throughput Screening AssaysHumansCell Cycle ProteinsATPases Associated with Diverse Cellular ActivitiesDrug DiscoveryProtein Kinase InhibitorsAntineoplastic AgentsNeoplasmsCell Line, TumorDrug DevelopmentQuinolines

MeSH Terms

ATPases Associated with Diverse Cellular ActivitiesDrug DevelopmentAntineoplastic AgentsHumansNeoplasmsQuinolinesCell Cycle ProteinsCell Line, TumorProtein Kinase InhibitorsDrug DiscoveryHigh-Throughput Screening Assays

Keywords

High-throughput screeningThroughputComputer scienceChemistryTelecommunicationsBiochemistryATPaseLuminescenceTrip13Rb-deficient CancersHigh Throughput Compound Screening

Advancing the development of TRIP13 inhibitors: A high-throughput screening approach

FAIR Checklist

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)